200 related articles for article (PubMed ID: 23207637)
21. Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
Zhang M; Zhu W; Ding N; Zhang W; Li Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):2225-9. PubMed ID: 23434226
[TBL] [Abstract][Full Text] [Related]
22. Identification of new shikonin derivatives as STAT3 inhibitors.
Qiu HY; Fu JY; Yang MK; Han HW; Wang PF; Zhang YH; Lin HY; Tang CY; Qi JL; Yang RW; Wang XM; Zhu HL; Yang YH
Biochem Pharmacol; 2017 Dec; 146():74-86. PubMed ID: 29066190
[TBL] [Abstract][Full Text] [Related]
23. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models.
Martínez-García D; Pérez-Hernández M; Korrodi-Gregório L; Quesada R; Ramos R; Baixeras N; Pérez-Tomás R; Soto-Cerrato V
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31412593
[TBL] [Abstract][Full Text] [Related]
24. Discovery of 4-methoxy-N-(1-naphthyl)benzenesulfonamide derivatives as small molecule dual-target inhibitors of tubulin and signal transducer and activator of transcription 3 (STAT3) based on ABT-751.
Wang X; Lu Y; Sun D; Qian J; Tu S; Yue W; Lin H; Tang H; Meng F; He Q; Xie Z; Zhang Y; Chen H; Ma S; Zuo Z; Ye F
Bioorg Chem; 2022 Aug; 125():105864. PubMed ID: 35584606
[TBL] [Abstract][Full Text] [Related]
25. Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide.
Wang X; Wu K; Fang L; Yang X; Zheng N; Du Z; Lu Y; Xie Z; Liu Z; Zuo Z; Ye F
Eur J Med Chem; 2021 Jun; 218():113362. PubMed ID: 33774344
[TBL] [Abstract][Full Text] [Related]
26. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
Zhang L; Liu P; Jiang Y; Fan D; He X; Zhang J; Luo B; Sui J; Luo Y; Fu X; Yang T
Eur J Med Chem; 2024 Jun; 272():116448. PubMed ID: 38704936
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
Yu W; Xiao H; Lin J; Li C
J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
Abdelgawad MA; Bakr RB; Omar HA
Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
[TBL] [Abstract][Full Text] [Related]
29. Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors.
LaPorte MG; Wang Z; Colombo R; Garzan A; Peshkov VA; Liang M; Johnston PA; Schurdak ME; Sen M; Camarco DP; Hua Y; Pollock NI; Lazo JS; Grandis JR; Wipf P; Huryn DM
Bioorg Med Chem Lett; 2016 Aug; 26(15):3581-5. PubMed ID: 27381083
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel STAT3 inhibitors bearing 2-acetyl-7-phenylamino benzofuran scaffold for antitumour study.
Wang F; Feng KR; Zhao JY; Zhang JW; Shi XW; Zhou J; Gao D; Lin GQ; Tian P
Bioorg Med Chem; 2020 Dec; 28(24):115822. PubMed ID: 33126089
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors.
Gomez C; Bai L; Zhang J; Nikolovska-Coleska Z; Chen J; Yi H; Wang S
Bioorg Med Chem Lett; 2009 Mar; 19(6):1733-6. PubMed ID: 19243938
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors.
Daka P; Liu A; Karunaratne C; Csatary E; Williams C; Xiao H; Lin J; Xu Z; Page RC; Wang H
Bioorg Med Chem; 2015 Mar; 23(6):1348-55. PubMed ID: 25698618
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
Feng KR; Wang F; Shi XW; Tan YX; Zhao JY; Zhang JW; Li QH; Lin GQ; Gao D; Tian P
Eur J Med Chem; 2020 Sep; 201():112428. PubMed ID: 32603980
[TBL] [Abstract][Full Text] [Related]
34. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition.
Xu S; Fan R; Wang L; He W; Ge H; Chen H; Xu W; Zhang J; Xu W; Feng Y; Fan Z
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):236-251. PubMed ID: 34894961
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and studies of small molecule STAT3 inhibitors.
Bhasin D; Cisek K; Pandharkar T; Regan N; Li C; Pandit B; Lin J; Li PK
Bioorg Med Chem Lett; 2008 Jan; 18(1):391-5. PubMed ID: 18006313
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
38. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways.
Xu WT; Shen GN; Luo YH; Piao XJ; Wang JR; Wang H; Zhang Y; Li JQ; Feng YC; Zhang Y; Zhang T; Wang SN; Wang CY; Jin CH
Chem Biol Interact; 2019 May; 304():148-157. PubMed ID: 30871965
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-κB and STAT3 inhibitors.
Zeng B; Cheng Y; Zheng K; Liu S; Shen L; Hu J; Li Y; Pan X
Bioorg Chem; 2021 Jun; 111():104973. PubMed ID: 34004586
[TBL] [Abstract][Full Text] [Related]
40. Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.
Su JC; Chang CH; Wu SH; Shiau CW
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1248-1255. PubMed ID: 30261753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
